한글목차

세계의 바이오의약품 시장은 2024년에 4,358억 2,000만 달러로 평가되었으며, 2030년까지 CAGR 8.76%로 성장하여 7,213억 1,000만 달러에 달할 것으로 예측됩니다.

바이오의약품은 단클론항체, 백신, 유전자 치료제, 유전자재조합단백질 등의 제품을 포함하여 생물학적 자원으로부터 생명공학 기법을 이용하여 제조되는 치료제로서, 다양하고 복잡한 질환의 치료를 목적으로 하는 의약품입니다. 세계 시장은 주로 만성질환의 증가 추세, 생명공학 기술의 지속적인 발전, 전 세계 고령화 인구의 증가에 의해 주도되고 있습니다.

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 바이오의약품 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 제품 유형별(단클론항체, 재조합 성장인자, 정제 단백질, 재조합 단백질, 재조합 호르몬, 백신, 재조합 효소, 세포 및 유전자 치료, 합성 면역조절제, 기타)
  • 치료 용도별(종양학, 염증성·감염증, 자가면역질환, 대사성 질환, 내분비질환, 심혈관질환, 신경질환, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 바이오의약품 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 바이오의약품 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 바이오의약품 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 바이오의약품 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 바이오의약품 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 바이오의약품 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Abbvie Inc.
• Amgen Inc.
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Johnson & Johnson
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• GlaxoSmithKline plc
• F. Hoffmann-La Roche Ltd.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Biopharmaceutical Market , valued at USD 435.82 Billion in 2024, is projected to experience a CAGR of 8.76% to reach USD 721.31 Billion by 2030. Biopharmaceuticals are therapeutic agents derived from biological sources using biotechnological methods, encompassing products such as monoclonal antibodies, vaccines, gene therapies, and recombinant proteins, designed to treat a wide array of complex diseases. The global market is primarily driven by the escalating prevalence of chronic conditions, continuous advancements in biotechnology, and an expanding aging population worldwide.

Key Market Drivers

The global biopharmaceutical market is significantly propelled by the increasing global prevalence of chronic and rare diseases. The rising incidence of conditions such as cancer, autoimmune disorders, and various genetic diseases creates an urgent demand for novel and effective therapeutic solutions that biopharmaceuticals are uniquely positioned to offer. These complex diseases often present considerable unmet medical needs, driving research and development towards treatments that promise higher efficacy and improved patient outcomes.

Key Market Challenges

A significant challenging factor hampering the growth of the Global Biopharmaceutical Market is the exceptionally high costs associated with extensive research and development initiatives. Developing novel biopharmaceutical products requires substantial capital investment due to the intricate scientific processes and advanced technologies involved. According to PhRMA's 2023 annual report, member companies invested $102.3 billion in research and development, underscoring the immense financial burden required for innovation in this sector. These costs often translate into lengthy funding cycles, consuming significant resources before any market returns can be realized.

Key Market Trends

The integration of advanced artificial intelligence into drug development processes is fundamentally reshaping the global biopharmaceutical market. This trend is driven by AI's ability to significantly accelerate discovery timelines and enhance the precision of therapeutic interventions. According to the European Federation of Pharmaceutical Industries and Associations, the pharmaceutical industry invested an estimated €55,000 million in research and development across Europe in 2024, a considerable portion of which is now being leveraged into AI-driven platforms. These technologies allow for rapid analysis of complex biological data, prediction of molecular interactions, and optimization of compound design, thereby streamlining preclinical research.

Key Market Players

• Abbvie Inc.
• Amgen Inc.
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Johnson & Johnson
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• GlaxoSmithKline plc
• F. Hoffmann-La Roche Ltd.

Report Scope:

In this report, the Global Biopharmaceutical Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biopharmaceutical Market , By Product Type:

• Monoclonal Antibodies
• Recombinant Growth Factors
• Purified Proteins
• Recombinant Proteins
• Recombinant Hormones
• Vaccines
• Recombinant Enzymes
• Cell and Gene Therapies
• Synthetic Immunomodulators
• Others

Biopharmaceutical Market , By Therapeutic Application:

• Oncology
• Inflammatory and Infectious Diseases
• Autoimmune Disorders
• Metabolic Disorders
• Hormonal Disorders
• Cardiovascular Diseases
• Neurological Diseases
• Other

Biopharmaceutical Market , By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biopharmaceutical Market .

Available Customizations:

Global Biopharmaceutical Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biopharmaceutical Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Vaccines, Recombinant Enzymes, Cell and Gene Therapies, Synthetic Immunomodulators, Others)
  • 5.2.2. By Therapeutic Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, Other)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Biopharmaceutical Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Therapeutic Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biopharmaceutical Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Therapeutic Application
  • 6.3.2. Canada Biopharmaceutical Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Therapeutic Application
  • 6.3.3. Mexico Biopharmaceutical Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Therapeutic Application

7. Europe Biopharmaceutical Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Therapeutic Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biopharmaceutical Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Therapeutic Application
  • 7.3.2. France Biopharmaceutical Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Therapeutic Application
  • 7.3.3. United Kingdom Biopharmaceutical Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Therapeutic Application
  • 7.3.4. Italy Biopharmaceutical Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Therapeutic Application
  • 7.3.5. Spain Biopharmaceutical Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Therapeutic Application

8. Asia Pacific Biopharmaceutical Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Therapeutic Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Biopharmaceutical Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Therapeutic Application
  • 8.3.2. India Biopharmaceutical Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Therapeutic Application
  • 8.3.3. Japan Biopharmaceutical Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Therapeutic Application
  • 8.3.4. South Korea Biopharmaceutical Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Therapeutic Application
  • 8.3.5. Australia Biopharmaceutical Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Therapeutic Application

9. Middle East & Africa Biopharmaceutical Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Therapeutic Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Biopharmaceutical Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Therapeutic Application
  • 9.3.2. UAE Biopharmaceutical Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Therapeutic Application
  • 9.3.3. South Africa Biopharmaceutical Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Therapeutic Application

10. South America Biopharmaceutical Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Therapeutic Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Biopharmaceutical Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Therapeutic Application
  • 10.3.2. Colombia Biopharmaceutical Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Therapeutic Application
  • 10.3.3. Argentina Biopharmaceutical Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Therapeutic Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Biopharmaceutical Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbvie Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Amgen Inc.
• 15.3. Bristol-Myers Squibb Company
• 15.4. Eli Lilly and Company
• 15.5. Johnson & Johnson
• 15.6. Novartis AG
• 15.7. Novo Nordisk A/S
• 15.8. Pfizer Inc.
• 15.9. GlaxoSmithKline plc
• 15.10. F. Hoffmann-La Roche Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer